NCT07627516 Clinical Study of the Efficacy and Safety of Spinal Cord Stimulation in Patients With Limb Motor Dysfunction Following Stroke
| NCT ID | NCT07627516 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Second Affiliated Hospital, Zhejiang University, School of Medicine |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 6 participants |
| Start Date | 2026-01-01 |
| Primary Completion | 2028-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 6 participants in total. It began in 2026-01-01 with a primary completion date of 2028-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To assess the efficacy and safety of spinal cord stimulation in treating post-stroke limb motor disorders, we propose to conduct a clinical trial. This study seeks to accumulate additional clinical experience with spinal cord stimulation in patients suffering from post-stroke limb motor disorders and to enhance their quality of life.
Eligibility Criteria
Inclusion Criteria: 1. Hemiparesis resulting from a single ischemic or hemorrhagic stroke, with a disease duration of ≥6 months. 2. Aged between 20 and 80 years (inclusive). 3. Received regular rehabilitation therapy after stroke but with poor recovery of limb motor function; Fugl-Meyer Assessment upper extremity score \>7 and \<45, and lower extremity score \>5 and \<30. 4. Partially preserved sensory function. Exclusion Criteria: 1. Severe systemic diseases (e.g., neurological disorders other than stroke, cancer, severe circulatory or respiratory diseases, liver or kidney failure, etc.) or other conditions that may impair the subject's motor or cognitive function. 2. Presence of spinal cord-related nerve compression that could cause severe functional impairment. 3. Women who are pregnant or breastfeeding. 4. Use of anticoagulant, antiplatelet, antispasmodic, or antiepileptic medications prior to enrollment or during the study period. 5. Severe joint contracture that, in the clinical investigator's opinion, precludes participation in the study. 6. Severe mental illness or intellectual disability that prevents cooperation with treatment or follow-up questionnaires, with a Mini-Mental State Examination (MMSE) score \<24. 7. Presence of other implanted medical devices. 8. Severe claustrophobia.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07627516 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 80 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07627516 currently recruiting?
Yes, NCT07627516 is actively recruiting participants. Contact the research team at d.chengao@163.com for enrollment information.
Where is the NCT07627516 trial being conducted?
This trial is being conducted at Hangzhou, China.
Who is sponsoring the NCT07627516 clinical trial?
NCT07627516 is sponsored by Second Affiliated Hospital, Zhejiang University, School of Medicine. The trial plans to enroll 6 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.